0001437749-17-019919.txt : 20171129 0001437749-17-019919.hdr.sgml : 20171129 20171129162442 ACCESSION NUMBER: 0001437749-17-019919 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171127 FILED AS OF DATE: 20171129 DATE AS OF CHANGE: 20171129 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cohen Daniel L CENTRAL INDEX KEY: 0001672300 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36913 FILM NUMBER: 171228608 MAIL ADDRESS: STREET 1: 2656 CROSSPARK ROAD, SUITE 100 CITY: CORALVILLE STATE: IA ZIP: 52241 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: KEMPHARM, INC CENTRAL INDEX KEY: 0001434647 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 205894398 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2500 CROSSPARK ROAD, SUITE E126 CITY: CORALVILLE STATE: IA ZIP: 52241 BUSINESS PHONE: 319-665-2575 MAIL ADDRESS: STREET 1: 2500 CROSSPARK ROAD, SUITE E126 CITY: CORALVILLE STATE: IA ZIP: 52241 FORMER COMPANY: FORMER CONFORMED NAME: KEMPHARM INC DATE OF NAME CHANGE: 20080507 4 1 rdgdoc.xml FORM 4 X0306 4 2017-11-27 0001434647 KEMPHARM, INC KMPH 0001672300 Cohen Daniel L C/O KEMPHARM, INC. 2500 CROSSPARK ROAD, SUITE E126 CORALVILLE IA 52241 1 EVP, Govt. & Public Relations Common Stock 2017-11-27 4 P 0 1145 3.70 A 26145 D Common Stock 2017-11-27 4 P 0 1310 3.75 A 27455 D Common Stock 2017-11-27 4 P 0 2990 3.80 A 30445 D Common Stock 2017-11-27 4 P 0 2055 3.85 A 32500 D Common Stock 2017-11-29 4 G 0 2500 0 D 30000 D Common Stock 2017-11-29 4 G 0 1250 0 A 1250 I By Daughter. Common Stock 2017-11-29 4 G 0 1250 0 A 1250 I By Daughter. The shares are held in an investment account for the benefit of the Reporting Person's daughter. The Reporting Person may be deemed to have indirect beneficial interest in such shares based on his investment control over the daughter's account. The shares are held in an investment account for the benefit of the Reporting Person's daughter. The Reporting Person may be deemed to have indirect beneficial interest in such shares based on his investment control over the daughter's account. /s/ Timothy J. Sangiovanni, Attorney-in-Fact for Daniel L. Cohen 2017-11-29